NIH/Large clinical trial/COVID-19

Perhaps details are missed:



The ResCue trial is Phase 2. ACTIV-6 is phase 3. It is not the same as OPKs. But PERHAPS OPK could roll into a phase 3 under Activ 6 if they had safe and efficacious data/results from their phase 2. That is...if a 4 week study can be completed in less than 12 months.

Hey now, why don't you cut the cuddly, good.....no, very very good.... doctor some slack, ok? After all, it's only been 323 days since the FDA said "Opko, you may proceed." I'm now thinking that the Miami mavens are planning a bash for June 1, 2021, like a group celebration. Why not wait until June 1 to release 61 day old results from Q1, while having an anniversary party for the FDA green light (the festivities will of course include an 80% off coupon for a 4K score test to mirror the 80% decline in the stock price, half price on a one month's supply of Rayaldee for CKD Stage 3 and 4 attendees, topped off by a clown dressed up as a Claros device with an inhaler enveloping his/her/its/they/she/him face). And while special guests, the petrified Starland Vocal Band, sing an infinite loop of Afternoon Delight, which the execs are sure represents current pop tastes, the C suite also sneaks in the annual meeting. So they kill three birds, and all non-bonuses shareholders, with one party. Newest BOD leech Prem will be the emcee, in colorful garb worthy of South Florida, complete with sockless loafers, or bell bottoms with flip flops.